(Q43629634)

English

Long-term mortality results of the randomized controlled study comparing bromocriptine to which levodopa was later added with levodopa alone in previously untreated patients with Parkinson's disease.

scientific article published in May 2001

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11391747%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

Long-term mortality results of the randomized controlled study comparing bromocriptine to which levodopa was later added with levodopa alone in previously untreated patients with Parkinson's disease (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11391747%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

Parkinson's disease

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Maryse Lapeyre-Mestre

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11391747%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

Jean-Michel Sénard

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11391747%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

author name string

J L Montastruc

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11391747%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

K Desboeuf

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11391747%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

O Rascol

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11391747%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

C Brefel-Courbon

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11391747%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

language of work or name

0 references

publication date

1 May 2001

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11391747%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

Movement Disorders

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11391747%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

16

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11391747%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11391747%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

511-514

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11391747%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

The initial treatment of Parkinson's disease should begin with levodopa

1 reference

https://api.crossref.org/works/10.1002%2FMDS.1093

21 January 2018

Treatment of Parkinson's disease should begin with a dopamine agonist

1 reference

https://api.crossref.org/works/10.1002%2FMDS.1093

21 January 2018

A randomised controlled study comparing bromocriptine to which levodopa was later added, with levodopa alone in previously untreated patients with Parkinson's disease: a five year follow up.

1 reference

https://api.crossref.org/works/10.1002%2FMDS.1093

21 January 2018

A five-year study of the incidence of dyskinesia in patients with early Parkinson's disease who were treated with ropinirole or levodopa

1 reference

https://api.crossref.org/works/10.1002%2FMDS.1093

21 January 2018

Bromocriptine lessens the incidence of mortality in L-dopa-treated parkinsonian patients: prado-study discontinued

1 reference

https://api.crossref.org/works/10.1002%2FMDS.1093

21 January 2018

The sydney multicentre study of Parkinson's disease: progression and mortality at 10 years

1 reference

https://api.crossref.org/works/10.1002%2FMDS.1093

21 January 2018

The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease

1 reference

https://api.crossref.org/works/10.1002%2FMDS.1093

21 January 2018

Prevalence of parkinsonian signs and associated mortality in a community population of older people.

1 reference

https://api.crossref.org/works/10.1002%2FMDS.1093

21 January 2018

Mortality from Parkinson disease.

1 reference

https://api.crossref.org/works/10.1002%2FMDS.1093

21 January 2018

Dopamine agonists and neuroprotection in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1002%2FMDS.1093

21 January 2018

Neuroprotection in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1002%2FMDS.1093

21 January 2018

Mortality in DATATOP: a multicenter trial in early Parkinson's disease. Parkinson Study Group

1 reference

https://api.crossref.org/works/10.1002%2FMDS.1093

21 January 2018

Identifiers

10.1002/MDS.1093

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11391747%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11391747%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43629634&oldid=2101985210"